Travis Hansen, MD
Child & Adolescent Psychiatry · Mankato, MNNPI 1164558151
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 36.2% of the total. Reporting peaked in 2024 at $148 and has fallen 81.2% since, to $28 in 2025.
Across 20 payments — averaging $17.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$129
- Neuronetics, Inc.$64
- Acadia Pharmaceuticals Inc$33
- Corium, LLC$29
- Alkermes, Inc.$24
- Teva Pharmaceuticals USA, Inc.$19
- plus $59 from 4 others
What the payments were for
- Food & beverage$358100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 6 | $129 |
| Neuronetics, Inc. | 2 | $64 |
| Acadia Pharmaceuticals Inc | 2 | $33 |
| Corium, LLC | 3 | $29 |
| Alkermes, Inc. | 2 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| AbbVie | 1 | $15 |
| Novo Nordisk | 1 | $15 |
| Almatica Pharma LLC | 1 | $15 |
| Harmony Biosciences LLC | 1 | $13 |
How this compares
$358 in reported general payments places this provider in the 75th percentile of 21 child & adolescent psychiatry providers in Minnesota.
See all child & adolescent psychiatry providers in Minnesota →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metyrosine | 12 | $340,304 |
| ConcertaMethylphenidate Hcl | 11 | $5,923 |
| Duloxetine Hcl | 17 | $2,954 |
| Paliperidone ErPaliperidone | 13 | $2,277 |
| Escitalopram Oxalate | 13 | $391 |
| Risperidone | 26 | $359 |
| Mirtazapine | 15 | $277 |
| Clonidine Hcl | 21 | $260 |
| Propranolol Hcl | 11 | $236 |
| Fluoxetine Hcl | 24 | $204 |
| Lorazepam | 11 | $178 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 13 | $143 |
| Metformin Hcl | 11 | $76 |
| Olanzapine | 13 | $36 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Mankato
- Sreelatha SpiekerMankato$854
- Peter KarachunskiMinneapolis$22K
- Kim HoltmeierGolden Valley$5K
- Israel SokeyePlymouth$1K
- Carl HansenSt Louis Park$396
- Michael AdelmanBaxter$313
- Lynda BargerGolden Valley$192
- Tan NgoBrooklyn Park$119
- Jonathan JensenMinneapolis$109
- Richard PetersonChaska$89
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.